Polyclonal Antibody Market Size, Growth, Demand, Opportunities & Forecast To 2027

Antibodies are the type of globular proteins produced by the plasma cells. Polyclonal antibodies are produced by different types of plasma B cells and bind to different epitopes in the same antigen. Polyclonal antibodies are heterogeneous mixture of antibodies and are inexpensive to produce. Polyclonal antibodies are used in therapeutics as well as in research applications.

Major players operating in the global polyclonal antibody market are Abcam plc, GenScript, Merck KGaA., IgY Immune Technologies & Life Sciences Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., Genway Biotech, Inc., Geno Technology Inc., DC Biosciences Ltd., Good Biotech Corp, Rockland Immunochemicals, Inc., EpiGentek Group Inc., Innovagen AB., and GeneTex, Inc. among others.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4347

Market Dynamics

Rising incidence of cancer is expected to drive the global polyclonal antibody market growth. For instance, according to an article published by the Cancer Research UK, 367,167 new cases of cancer were reported between 2015 and 2017 in the U.K.

Moreover, ongoing development of polyclonal antibodies is expected to drive the market growth. For instance, in March 2020, GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced that the company is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19. The recombinant anti-coronavirus 19 hyperimmune gammaglobulin (rCIG) is in development to treat high-risk and severely ill individuals infected with COVID-19.

Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications. Moreover, increasing incidence of cancer across the globe is expected to boost the market growth. According to an article published by Cancer Research UK in 2015, 55,122 new cases of breast cancer were registered in 2015. In the U.K., breast cancer was the most common cancer, accounting for 15% of all new cancer cases in 2015.

The global polyclonal antibody market is estimated to be valued at US$ 943.6 million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).

Rising cases of infectious diseases are expected to propel growth of the global polyclonal antibody market.

Rising incidence of infectious diseases such as Ebola virus worldwide, especially in under-developed countries, is expected to drive the market growth during the forecast period. For instance, according to an article published by the World Health Organization (WHO) in February 2020, the outbreak of Ebola virus in West Africa was the largest outbreak during 2014-2016 and it still continues in various countries

You can Buy This Report from Here @ https://www.coherentmarketinsights.com/insight/buy-now/4347

The ongoing development of polyclonal antibodies in North America is expected to drive the market growth.

North America is expected to hold dominant position in the global polyclonal antibody market owing to ongoing research and development in the region. For instance, in August 2018, SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti-Ebola immunotherapy, SAB-139, offers100% protection against a lethal dose of the Ebola virus in an animal study published in The Journal of Infectious Diseases. The study was conducted by the National Interagency Confederation for Biological Research in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC).

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.